Evinova
Evinova's digital platform will give study sites the ability to monitor patients enrolled in Quantum Leap's clinical trial for interstitial lung disease.
The pharma giant's new health tech company will operate as a separate business and scale the company's already established digital technologies to enhance clinical trials.